SP1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Although our study revealed that Sp1 is a pivotal mediator of miR-7a/b activity in CFs, future research is required to determine the physiological effects of miR-7a/b and Sp1 in mice and humans.